For full-year 2023, Clover Health issues its partial guidance as follows: Insurance Segment: Insurance revenues are expected to be in the range of $1.15 billion to $1.20 billion in 2023, as compared to our most recently issued 2022 guidance range of $1.0 billion to $1.1 billion. Insurance MCR is expected to be in the range of 89% – 91% in 2023. Non-Insurance Segment: Non-Insurance revenues are expected to be in the range of $0.75 billion to $0.80 billion in 2023. Non-Insurance MCR is expected to be in the range of 98% – 100% in 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLOV:
- Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023
- Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
- Unusually active option classes on open December 21st
- Clover Health Issues December 2022 Investor Frequently Asked Questions
- Dr. Anna Loengard Joins Clover Health Board of Directors
